HEADER TRANSCRIPTION 21-JAN-22 7QVJ TITLE ESTROGEN RECEPTOR ALPHA IN COMPLEX WITH COMPOUND 29 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LIGAND-BINDING DOMAIN OF OESTROGEN NUCLEAR HORMONE RECEPTOR, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.BREED REVDAT 4 07-FEB-24 7QVJ 1 REMARK REVDAT 3 08-MAR-23 7QVJ 1 JRNL REVDAT 2 15-FEB-23 7QVJ 1 JRNL REVDAT 1 01-FEB-23 7QVJ 0 JRNL AUTH J.S.SCOTT,D.STEAD,B.BARLAAM,J.BREED,R.J.CARBAJO, JRNL AUTH 2 E.CHIARPARIN,N.CURETON,P.R.J.DAVEY,D.I.FISHER,E.T.GANGL, JRNL AUTH 3 T.GREBE,R.D.GREENWOOD,S.HANDE,H.HATOUM-MOKDAD,S.J.HUGHES, JRNL AUTH 4 T.A.HUNT,T.JOHNSON,S.L.KAVANAGH,T.C.M.KLINOWSKA, JRNL AUTH 5 C.J.B.LARNER,M.LAWSON,A.S.LISTER,D.LONGMIRE,S.MARDEN, JRNL AUTH 6 T.M.MCGUIRE,C.MCMILLAN,L.MCMURRAY,C.J.MORROW,J.W.M.NISSINK, JRNL AUTH 7 T.A.MOSS,D.H.O'DONOVAN,R.POLANSKI,S.STOKES,K.THAKUR, JRNL AUTH 8 D.TRUEMAN,C.TRUMAN,M.J.TUCKER,H.WANG,N.WHALLEY,D.WU,Y.WU, JRNL AUTH 9 B.YANG,W.YANG JRNL TITL DISCOVERY OF A POTENT AND ORALLY BIOAVAILABLE ZWITTERIONIC JRNL TITL 2 SERIES OF SELECTIVE ESTROGEN RECEPTOR DEGRADER-ANTAGONISTS. JRNL REF J.MED.CHEM. V. 66 2918 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36727211 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01964 REMARK 2 REMARK 2 RESOLUTION. 1.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 50935 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.840 REMARK 3 FREE R VALUE TEST SET COUNT : 2466 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.020 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.51 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3435 REMARK 3 BIN R VALUE (WORKING SET) : 0.2230 REMARK 3 BIN FREE R VALUE : 0.2400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.93 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 178 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3585 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 65 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.52 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.88780 REMARK 3 B22 (A**2) : -4.38480 REMARK 3 B33 (A**2) : -0.50300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.64890 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.109 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.097 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.113 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.100 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.954 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3763 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5120 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1284 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 69 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 550 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3763 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 504 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4470 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.23 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.01 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.50 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 19.5251 -6.5425 23.3426 REMARK 3 T TENSOR REMARK 3 T11: -0.1420 T22: -0.0539 REMARK 3 T33: -0.1371 T12: 0.0511 REMARK 3 T13: -0.0010 T23: 0.0141 REMARK 3 L TENSOR REMARK 3 L11: 1.6332 L22: 1.4371 REMARK 3 L33: 1.8579 L12: -0.3622 REMARK 3 L13: -0.8115 L23: -0.0519 REMARK 3 S TENSOR REMARK 3 S11: -0.0021 S12: -0.1657 S13: -0.0802 REMARK 3 S21: -0.0218 S22: 0.0222 S23: 0.0011 REMARK 3 S31: 0.0183 S32: 0.2927 S33: -0.0201 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -3.5427 6.6553 21.4892 REMARK 3 T TENSOR REMARK 3 T11: -0.0899 T22: -0.1098 REMARK 3 T33: -0.1055 T12: 0.0916 REMARK 3 T13: 0.0479 T23: 0.0357 REMARK 3 L TENSOR REMARK 3 L11: 1.9956 L22: 0.5880 REMARK 3 L33: 2.0366 L12: 0.3528 REMARK 3 L13: -0.0851 L23: -0.0944 REMARK 3 S TENSOR REMARK 3 S11: 0.0541 S12: -0.0415 S13: 0.0306 REMARK 3 S21: 0.0446 S22: 0.1327 S23: 0.0927 REMARK 3 S31: -0.2811 S32: -0.2586 S33: -0.1867 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7QVJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1292120429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97622 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50941 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.680 REMARK 200 RESOLUTION RANGE LOW (A) : 43.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.87700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 6SUO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, MAGNESIUM CHLORIDE, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.45000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.89500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.45000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.89500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 726 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 728 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 337 REMARK 465 SER A 338 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 LYS A 529 REMARK 465 SER A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 GLY B 303 REMARK 465 SER B 304 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 330 CG CD OE1 OE2 REMARK 470 TYR A 331 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 332 CG OD1 OD2 REMARK 470 THR A 334 OG1 CG2 REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 PRO A 336 CG CD REMARK 470 GLU A 339 CG CD OE1 OE2 REMARK 470 MET A 342 CG SD CE REMARK 470 GLU A 397 CG CD OE1 OE2 REMARK 470 LYS A 401 NZ REMARK 470 ASN A 413 CG OD1 ND2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 MET A 421 CG SD CE REMARK 470 GLU A 423 CG CD OE1 OE2 REMARK 470 MET A 437 CG SD CE REMARK 470 TYR A 459 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 PHE A 461 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 468 OG REMARK 470 LEU A 469 CG CD1 CD2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 GLN A 498 CG CD OE1 NE2 REMARK 470 LYS A 520 CE NZ REMARK 470 VAL A 533 CG1 CG2 REMARK 470 HIS B 305 CG ND1 CD2 CE1 NE2 REMARK 470 MET B 306 CG SD CE REMARK 470 LEU B 308 CG CD1 CD2 REMARK 470 ASP B 332 CG OD1 OD2 REMARK 470 PHE B 337 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 339 CD OE1 OE2 REMARK 470 HIS B 373 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 397 CD OE1 OE2 REMARK 470 LYS B 401 CE NZ REMARK 470 ASN B 413 CG OD1 ND2 REMARK 470 LYS B 416 CG CD CE NZ REMARK 470 VAL B 418 CG1 CG2 REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 GLU B 423 CG CD OE1 OE2 REMARK 470 MET B 437 CG SD CE REMARK 470 SER B 463 OG REMARK 470 SER B 464 OG REMARK 470 THR B 465 OG1 CG2 REMARK 470 LEU B 466 CG CD1 CD2 REMARK 470 LYS B 467 CG CD CE NZ REMARK 470 SER B 468 OG REMARK 470 LEU B 469 CG CD1 CD2 REMARK 470 GLU B 470 CG CD OE1 OE2 REMARK 470 GLU B 471 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 ASP B 473 OD1 OD2 REMARK 470 LYS B 492 CG CD CE NZ REMARK 470 LYS B 520 CE NZ REMARK 470 GLU B 523 CD OE1 OE2 REMARK 470 TYR B 526 CD1 CD2 CE1 CE2 CZ OH REMARK 470 MET B 528 CG SD CE REMARK 470 VAL B 533 CG1 CG2 REMARK 470 GLU B 542 CG CD OE1 OE2 REMARK 470 HIS B 547 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 548 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 549 CG CD1 CD2 REMARK 470 HIS B 550 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 ND2 ASN A 359 OH TYR B 328 3545 1.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 333 8.27 -66.93 REMARK 500 LEU A 408 74.08 -150.91 REMARK 500 MET B 306 80.32 -156.25 REMARK 500 TYR B 331 169.51 -46.46 REMARK 500 THR B 465 96.10 -162.14 REMARK 500 LEU B 466 49.46 -146.96 REMARK 500 LYS B 467 -80.67 -156.86 REMARK 500 LEU B 469 95.87 -53.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS B 467 SER B 468 53.28 REMARK 500 REMARK 500 REMARK: NULL DBREF 7QVJ A 307 554 UNP P03372 ESR1_HUMAN 307 554 DBREF 7QVJ B 307 554 UNP P03372 ESR1_HUMAN 307 554 SEQADV 7QVJ GLY A 303 UNP P03372 EXPRESSION TAG SEQADV 7QVJ SER A 304 UNP P03372 EXPRESSION TAG SEQADV 7QVJ HIS A 305 UNP P03372 EXPRESSION TAG SEQADV 7QVJ MET A 306 UNP P03372 EXPRESSION TAG SEQADV 7QVJ SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 7QVJ SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 7QVJ SER A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 7QVJ SER A 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 7QVJ GLY B 303 UNP P03372 EXPRESSION TAG SEQADV 7QVJ SER B 304 UNP P03372 EXPRESSION TAG SEQADV 7QVJ HIS B 305 UNP P03372 EXPRESSION TAG SEQADV 7QVJ MET B 306 UNP P03372 EXPRESSION TAG SEQADV 7QVJ SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 7QVJ SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 7QVJ SER B 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 7QVJ SER B 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQRES 1 A 252 GLY SER HIS MET ALA LEU SER LEU THR ALA ASP GLN MET SEQRES 2 A 252 VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SEQRES 3 A 252 SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER SEQRES 4 A 252 MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU SEQRES 5 A 252 VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE SEQRES 6 A 252 VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SEQRES 7 A 252 SER ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP SEQRES 8 A 252 ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO SEQRES 9 A 252 ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU SEQRES 10 A 252 GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SEQRES 11 A 252 SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE SEQRES 12 A 252 VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL SEQRES 13 A 252 TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU SEQRES 14 A 252 LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP SEQRES 15 A 252 THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU SEQRES 16 A 252 GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE SEQRES 17 A 252 LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU SEQRES 18 A 252 HIS LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO SER SEQRES 19 A 252 TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 20 A 252 HIS ALA PRO THR SER SEQRES 1 B 252 GLY SER HIS MET ALA LEU SER LEU THR ALA ASP GLN MET SEQRES 2 B 252 VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SEQRES 3 B 252 SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER SEQRES 4 B 252 MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU SEQRES 5 B 252 VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE SEQRES 6 B 252 VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SEQRES 7 B 252 SER ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP SEQRES 8 B 252 ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO SEQRES 9 B 252 ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU SEQRES 10 B 252 GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SEQRES 11 B 252 SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE SEQRES 12 B 252 VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL SEQRES 13 B 252 TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU SEQRES 14 B 252 LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP SEQRES 15 B 252 THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU SEQRES 16 B 252 GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE SEQRES 17 B 252 LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU SEQRES 18 B 252 HIS LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO SER SEQRES 19 B 252 TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 20 B 252 HIS ALA PRO THR SER HET H09 A 601 36 HET H09 B 601 36 HETNAM H09 2,2-BIS(FLUORANYL)-3-[(1~{R},3~{R})-1-[6-FLUORANYL-3- HETNAM 2 H09 [2-(3-FLUORANYLPROPYLAMINO)ETHOXY]-2-METHYL-PHENYL]-3- HETNAM 3 H09 METHYL-1,3,4,9-TETRAHYDROPYRIDO[3,4-B]INDOL-2- HETNAM 4 H09 YL]PROPAN-1-OL FORMUL 3 H09 2(C27 H33 F4 N3 O2) FORMUL 5 HOH *65(H2 O) HELIX 1 AA1 MET A 306 LEU A 310 5 5 HELIX 2 AA2 THR A 311 GLU A 323 1 13 HELIX 3 AA3 SER A 341 LYS A 362 1 22 HELIX 4 AA4 GLY A 366 LEU A 370 5 5 HELIX 5 AA5 THR A 371 SER A 395 1 25 HELIX 6 AA6 ARG A 412 LYS A 416 1 5 HELIX 7 AA7 GLY A 420 MET A 438 1 19 HELIX 8 AA8 GLN A 441 SER A 456 1 16 HELIX 9 AA9 LEU A 469 ALA A 493 1 25 HELIX 10 AB1 THR A 496 SER A 527 1 32 HELIX 11 AB2 SER A 536 HIS A 547 1 12 HELIX 12 AB3 ARG A 548 HIS A 550 5 3 HELIX 13 AB4 THR B 311 ALA B 322 1 12 HELIX 14 AB5 SER B 338 VAL B 364 1 27 HELIX 15 AB6 THR B 371 SER B 395 1 25 HELIX 16 AB7 ARG B 412 LYS B 416 1 5 HELIX 17 AB8 MET B 421 MET B 438 1 18 HELIX 18 AB9 GLN B 441 SER B 456 1 16 HELIX 19 AC1 GLU B 471 ALA B 493 1 23 HELIX 20 AC2 THR B 496 TYR B 526 1 31 HELIX 21 AC3 SER B 536 ALA B 546 1 11 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 CRYST1 106.900 51.790 85.510 90.00 93.86 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009355 0.000000 0.000631 0.00000 SCALE2 0.000000 0.019309 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011721 0.00000